Cidara Therapeutics
CDTX
CDTX
42 hedge funds and large institutions have $17.1M invested in Cidara Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
9% less funds holding
Funds holding: 46 → 42 (-4)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
42
Holding in Top 10
1
Calls
$13K
Puts
$1K
Top Buyers
| 1 | +$232K | |
| 2 | +$86K | |
| 3 | +$65K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$61.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$52K |
Top Sellers
| 1 | -$208K | |
| 2 | -$167K | |
| 3 | -$102K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$28K |